Does an early invasive strategy improve outcomes compared to a selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level?
In patients with NSTE-ACS and elevated troponin T receiving optimized medical therapy, an early invasive strategy was not shown to be superior to a selectively invasive approach.
We could not demonstrate that, given optimized medical therapy, an early invasive strategy was superior to a selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level.
Winter et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: